IVD

127 IVD Articles
Posted in IVD by amanda.pedersen on January 10, 2017
Illumina shares soared Tuesday after the company introduced its newest sequencer, the NovaSeq, that could one day enable researchers to sequence a genome for as little as $100.Amanda PedersenIllumina CEO Francis deSouza said the new NovaSeq, will enable genomic studies that were not possib... Continue
Posted in IVD by Nancy Crotti on December 22, 2016
New models based on test results may help doctors and patients decide whether and when to discontinue aggressive treatment.Nancy CrottiA routine blood test can predict how long cancer patients in palliative care will survive, researchers reported at an oncology conference in Singapore this week.Rese... Continue
Posted in IVD by amanda.pedersen on December 22, 2016
Clinical Genomics’ new blood test does the same thing as a 1970s test, only better.Amanda Pedersen If old dogs can indeed be taught new tricks, perhaps the same is true for blood tests. That appears to be the case with a new blood-based test for colorectal cancer (CRC) recurrence monitoring d... Continue
Posted in IVD by Jamie Hartford on December 15, 2016
State and local officials offered the company millions of dollars in tax breaks, and Siemens Healthineers is responding by adding 400–700 jobs at the Walpole, MA, facility over the next 10 years. Jamie HartfordSiemens will manufacture assays to run on the Atellica Solution analyzer at the Wal... Continue
Posted in IVD by Chris Newmarker on October 27, 2016
CEO Anne Wojcicki describes it as a “hot shiny object” for her industry. But the company wants to focus on core areas for now. Chris Newmarker23andMe—which has made a name for itself selling relatively affordable genetic tests to the masses—has halted its pursuit to create more advanced sequ... Continue
Posted in IVD by Kristopher Sturgis on October 14, 2016
A new technique developed by researchers at MIT can test tumors for drug susceptibility by measuring how cancer drugs affect the growth rate of cancerous tumors in single cells.Kristopher SturgisWhen it comes to cancer treatment, selecting cancer drugs can oftentimes be a process of trial and error.... Continue
Posted in IVD by Nancy Crotti on September 20, 2016
Would FDA regulation of laboratory-developed tests add cost and delays or prevent potential danger to patients? A Senate committee took on the topic this week.Nancy CrottiWho should be regulating laboratory-developed tests (LDTs)? Currently, that’s the purview of CMS via the Clinical Laboratory Im... Continue
Posted in IVD by Chris Newmarker on August 23, 2016
    Boston-based Emulate earlier this year raised $28 Million to commercialize its organs-on-chips technology. The goal is to create a lab-ready system to could aid in everything from drug development to consumer product design. Emulate's automated system includes organ chips, instrum... Continue
Posted in IVD by Chris Newmarker on August 23, 2016
    A placenta-on-a-chip, developed at the University of Pennsylvania, could help when it comes to figuring out the causes of premature birth.Read the full Qmed story.Continue >>[Image courtesy of University of Pennsylvania] Continue
Posted in IVD by Chris Newmarker on August 23, 2016
    The credit card–sized microfluidic devices—designed at MIT's research center in Singapore—are able to help scientists figure out how to safely use electric fields to boost cancer treatment.Read the full Qmed story.  Continue >>[Image courtesy of MIT] Continue
Posted in IVD by Chris Newmarker on August 23, 2016
    Tissue-engineered into a small plastic microfluidic device, the artificial lung presents an opportunity to test human lung response to drugs, toxins, and other conditions, according to the Los Alamos National Laboratory scientists who created it.Read the full Qmed story.Continue &... Continue
Posted in IVD by Chris Newmarker on August 23, 2016
    IBM researcher boast a lab-on-a-chip they've developed that is able to separate biological particles at the nanoscale, providing hope for detecting diseases such as cancer before symptoms appear. Tests of the chip, reported in the journal Nature Nanotechnology, showed it sepa... Continue
Posted in IVD by Chris Newmarker on August 23, 2016
    A microfluidic device created at Harvard University's Wyss Institute successfully emulates the way the endothelium and circulating blood interacts. The Wyss Institute research group microengineered hollow channels with human endothelial cells chemically "fixed" along the lining of... Continue
Posted in IVD by Chris Newmarker on August 23, 2016
    A microfluidic device created by MIT engineers has shown promise replicating the neuromuscular junction where nerve meets muscle. The device is roughly the size of a U.S. quarter and includes a single strip of muscle and a set of motor neurons. The neurons were genetically modifie... Continue
Posted in IVD by Chris Newmarker on August 23, 2016
    They could be replicating the connection between muscles or nerves, blood clotting, a lung, cancer, and much more. A host of recently announced microfluidic devices are recreating the human body on a chip, offering the hope of better understanding and diagnosis of disease. He... Continue
Posted in IVD by Nancy Crotti on August 11, 2016
A regulatory consultant explains how other medtech companies can avoid the problems that have beset the blood-testing startup.Nancy CrottiAny new medtech company could run into the problems that have troubled once-vaunted blood-testing company Theranos, according to regulatory consultant David Amor.... Continue
Posted in IVD by Chris Newmarker on August 2, 2016
The high tech giant’s scientists say the technology is able to separate biological particles at the nanoscale. Chris NewmarkerA new lab-on-a-chip developed at IBM could potentially allow physicians to detect diseases such as cancer before symptoms appear, the high tech giant announced this week.&n... Continue
Posted in IVD by Nancy Crotti on July 29, 2016
Elizabeth Holmes will explain Theranos’s testing methodology at the American Association for Clinical Chemistry annual meeting, but some question the decision to give her a podium.Nancy CrottiThe founder and CEO of secretive and embattled Theranos is scheduled to discuss the science behind the com... Continue
Posted in IVD by Kristopher Sturgis on July 22, 2016
Los Alamos National Laboratory scientists tissue-engineered an artificial lung into a small plastic microfluidic device, creating an opportunity to test human lung response to drugs, toxins, and other conditions.Kristopher SturgisResearchers from Los Alamos National Laboratory (LANL) nicknamed the p... Continue
Posted in IVD by Kristopher Sturgis on July 21, 2016
The new technology was designed to make testing for malaria and other diseases including cancer as cheap and easy as a take home pregnancy test.Kristopher SturgisThe technology involves simple paper strips that can detect a variety of different diseases for just 50 cents per strip, according to the ... Continue